Skip to main content

Biological Markers for Staging of Gastric Cancer?

  • Conference paper
Gastric Cancer

Abstract

In the strict sense of the term, biological markers of tumors are substances — such as enzymes, hormones, or antigens — which are produced by the respective tumor and released into the body fluids where they may be detected. However, in a broader sense, the term includes characteristic reactions of the organism against the tumor, such as the formation of antibodies or cellular immune factors to tumor antigens. There are several examples of the successful application of such biological markers for the diagnosis or postoperative follow-up of human malignancies: the determination of AFP in liver carcinoma [13], of β-HCG in chorionic carcinoma [15], of CEA in colon carcinoma [14], and of EBV-antibodies in Burkitt lymphoma [9].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Björklund, B.: Tissue polypeptide antigen; review of physical chemistry and clinical application. In: Clinical application of carcinoembryonic antigen assay. Krebs, B. P., Lalanne, C. M., Schneider, M. (eds.), pp. 59–63. Amsterdam, Oxford: Excerpta Medica 1978

    Google Scholar 

  2. Bone, G., Lauder, I.: Cellular immunity, peripheral blood lymphocyte count and pathological staging of tumours in the gastrointestinal tract. Cancer 30, 215–221 (1974)

    Article  CAS  Google Scholar 

  3. Bone, G., Appleton, D. R., Venables, C. W.: Cutaneous delayed hypersensitivity responses to 2–4 dinitrochlorobenzene — a prognostic guide in malignant disease. Br. J. Surg. 60, 906 (1973)

    Article  PubMed  CAS  Google Scholar 

  4. Costanza, M. E., Das, S., Nathanson, L., Rule, A., Schwartz, R. S.: Carcinoembryonic antigen. Cancer 33, 583–590(1974)

    Article  PubMed  Google Scholar 

  5. Daver, A., Wafflart, J., Ben Boueli, A., Minier, J. F., Larra, F.: β2-microglobulin (β2-micro) and carcinoembryonic antigen (CEA) in intestinal cancers — a correlation with stage of disease. In: Clinical application of carcinoembryonic antigen assay. Krebs, B. P., Lalanne, C. M., Schneider, M. (eds.), pp. 460–465. Amsterdam, Oxford: Excerpta Medica 1978

    Google Scholar 

  6. Fuks, A., Banjo, Ch., Shuster, J., Freedmann, S. O., Gold, P.: Carcinoembryonic antigen (CEA): Molecular biology and clinical significance. Biochem. Biophys. Acta 417, 123–152 (1974)

    Google Scholar 

  7. Hamasaki, K.: Cell-mediated immunity against digestive organ cancers: leukocyte migration inhibitory factor activity as an immunological parameter. Acta Med. Okayama 31, 147–159 (1977)

    PubMed  CAS  Google Scholar 

  8. Hansen, H. J., Snyder, J. J., Miller, E., Vandevoorde, J. P., Miller, O. N., Hines, L. R., Burns, J. J.: Carcinoembryonic antigen (CEA) assay. Hum. Pathol. 5, 139–147 (1974)

    Article  PubMed  CAS  Google Scholar 

  9. Henle, W., Henle, G., Gunvin, P., Klein, G., Clifford, P., Single, S.: Patterns of antibodies to Epstein-Barr-Virus induced early antigens in Burkitt’s lymphoma. Comparison of dying patients with long-term survivors. J. Natl. Cancer Inst. 50, 1163 (1973)

    PubMed  CAS  Google Scholar 

  10. Johnson, M. W., Maibach, H. I., Salmon, S. E.: Skin reactivity in patients with cancer. Impaired delayed hypersensitivity or faulty inflammatory response? N. Engl. J. Med. 284, 1255–1257 (1971)

    Article  PubMed  CAS  Google Scholar 

  11. Klein, G.: Tumour antigens. Biochem. Soc. Trans. 4, 8–9 (1976)

    PubMed  CAS  Google Scholar 

  12. Lamerz, R., Fateh-Moghadam, A.: Carcinofetale Antigene. III. Andere Carcinofetale Antigene. Klin. Wochenschr. 53, 403–417 (1975)

    Article  PubMed  CAS  Google Scholar 

  13. Lamerz, R., Fateh-Moghadam, A.: Carcinofetale Antigene. I. Alpha-Fetoprotein. Klin. Wochenschr. 53, 147–169 (1975)

    Article  PubMed  CAS  Google Scholar 

  14. Lehmann, F. G.: Serologische Tumordiagnostik. Internist (Berlin) 16, 214–222 (1975)

    CAS  Google Scholar 

  15. Lehmann, F. G.: Kongreßbericht: 5th meeting of the International Research Group of Carcino-Embryonic Proteins (IRGCP). Inn. Med. 4, 388–390 (1977)

    Google Scholar 

  16. Gerfo, P., Pennington, G.: Current status of carcinoembryonic antigen. Prog. Clin. Cancer 6, 65–71(1975)

    PubMed  Google Scholar 

  17. Martin, E. W., James, K. K., Hurtubise, P. E., Catalano, P., Minton, J. P.: The use of CEA as an early indicator for gastrointestinal tumor recurrence and second-look procedures. Cancer 39, 440–446(1977)

    Article  PubMed  Google Scholar 

  18. Pant, K. D., Dahlman, H. L., Goldenberg, D. M.: A putatively new antigen (CSAp) associated with gastrointestinal and ovarian neoplasia. Immunol. Commun. 6, 411–421 (1977)

    PubMed  CAS  Google Scholar 

  19. Pappas, A., Scheurlen, P. G.: Lymphocyte transformation in malignant diseases. Communication II: Results in reticulo- and lymphoproliferative diseases as well as in carcinomas. In: Applied tumor immunology. Götz, H., Bücherl, E. S. (eds.), pp. 305–331. Berlin, New York: de Gruyter 1975

    Google Scholar 

  20. Rapp, W., Matzku, S., Wurster, K. H.: Stand der Isolierung CEA-ähnlicher Substanzen aus menschlicher Tumormagenschleimhaut. In: Tumorantigene in der Gastroenterologie. Lehmann, F. G. (ed.), pp. 39–43. Gräfelfing: Demeter 1976

    Google Scholar 

  21. Staab, H. J., Anderer, F. A., Stumpf, E., Fischer, R.: Second-look surgery of gastrointestinal carcinoma and the potential value of CEA monitoring. In: Clinical application of carcinoembryonic antigen assay. Krebs, B. P., Lalanne, C. M., Schneider, M. (eds.), pp. 94–100. Amsterdam, Oxford: Excerpta Medica 1978

    Google Scholar 

  22. Stillman, A., Zamcheck, N.: Recent advances in immunologic diagnosis of digestive tract cancer. Digest. Dis. 15, 1003–1018 (1970)

    Article  CAS  Google Scholar 

  23. Trejdosiewicz, L. K., Dykes, P. W.: And-tumour monocyte activity in gastric carcinoma patients receiving intra-tumoral C. parvum. In: The macrophage and cancer. James K., McBride, B., Stuart, A. (eds.), pp. 426–437. Edinburgh: Econoprint 1977

    Google Scholar 

  24. Vuento, M., Ruoslahti, E., Pihko, H., Svenberg, T., Ihamäki, T., Siurala, M.: Carcinoembryonic antigen-like substance in gastric juice. Immunochemistry 13, 313–316 (1976)

    Article  PubMed  CAS  Google Scholar 

  25. Zöller, M., Matzku, S., Lernhardt, W., Schulz, U.: Evaluation of different antigen sources for leukocyte migration testing of gastrointestinal cancer patients. In: Clinical application of carcinoembryonic antigen assay. Krebs, B. P., Lalanne, C. M., Schneider, M. (eds.), pp. 155–160. Amsterdam, Oxford: Excerpta Medica 1978

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1979 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Heymer, B., Quentmeier, A. (1979). Biological Markers for Staging of Gastric Cancer?. In: Herfarth, C.H., Schlag, P.M. (eds) Gastric Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67368-9_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-67368-9_23

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-67370-2

  • Online ISBN: 978-3-642-67368-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics